About TUROCTOCOG ALFA PEGOL
            
            Class: | Recombinant coagulation factor VIII (FVIII)  
Use: | Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency)  
Adult dose: | Individualized based on severity of hemophilia and bleeding episodes; typically, 20-40 IU/kg every 3-5 days for prophylaxis, adjusted based on clinical response  
Pediatric dose: | Individualized; generally similar to adult dosing, with adjustments based on weight and clinical response  
Side effects: | Heada
         
        
            
                
                
                    
                        Drug Class
                    
                    Recombinant coagulation factor VIII (FVIII)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency)
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator (2°C to 8°C); do not freeze; can be stored at room temperature (up to 25°C) for a maximum of 3 months; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Novo Nordisk A/S, DENMARK
                    
                    
                    Package Size
                    1 Glass Vial (Powder) + 1 Sterile Vial Adapter + 1 Prefilled Syringe (Solvent - 4 ml) + 1 Plunger Road
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 5374.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Individualized based on severity of hemophilia and bleeding episodes; typically, 20-40 IU/kg every 3-5 days for prophylaxis, adjusted based on clinical response
                    
                    
                        Pediatric Dose
                    
                    
                        Individualized; generally similar to adult dosing, with adjustments based on weight and clinical response
                    
                 
                
                
                    
                        Side Effects
                    
                    Headache, infusion site reactions, nausea, arthralgia, and potential for development of inhibitors to factor VIII
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Known hypersensitivity to TUROCTOCOG ALFA PEGOL or any components of the formulation; history of severe allergic reactions to factor VIII products
         
        
        
            
                Important Warnings
            
            Risk of thromboembolic events; monitor for signs of allergic reactions; patients with pre-existing cardiovascular disease may be at increased risk; ensure adequate hydration to prevent thrombotic complications
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.